What We're Reading: Page 185
Industry reads hand-picked by our editors
Aug 18, 2020
Aug 17, 2020
-
The New York TImes
Clinical Trials of Coronavirus Drugs Are Taking Longer Than Expected
-
Financial Times
CureVac vows 'ethical margin on price of Covid-19 vaccine
-
Endpoints News
In blow to anti-aging field, Unity Biotechnology fails first major study, cuts lead program
-
STAT
Seven months later, what we know — and don't know — about Covid-19
Aug 14, 2020
-
The Wall Street Journal
Covid-19 Vaccines Won’t Come With Copays, U.S. Health Official Says
-
Bloomberg Law
‘Pharma Bro’ Coordinated Antitrust Scheme From Jail, FTC Says
-
CNBC
This biotech CEO figured out Covid testing for 50 firms with 12-hour turnaround
-
STAT
Large study suggests blood plasma can help treat Covid-19, with caveats
Aug 13, 2020
-
The Boston Globe
A new approach to ALS drug trials gives patients hope
-
The Wall Street Journal
Beset by Coronavirus, Health Authorities Brace for Flu Season
-
Endpoints News
Novartis' CAR-T partner in China wraps $383M take-private deal engineered by CEO
-
STAT
Deaths from the most common lung cancer are falling fast, hinting at the impact of improved treatment
Aug 12, 2020
-
The New York Times
How Russia’s Rushed Covid-19 Vaccine Could Backfire
-
The Wall Street Journal
Kodak Insider Makes Well-Timed Stock Gift of $116 Million to Religious Charity He Started
-
Reuters
Vir Biotech to begin mid-to-late stage study of COVID-19 drug candidate in August
-
Evaluate Vantage
Contingent value is back in vogue
Aug 11, 2020
Aug 10, 2020
-
The New York Times
This Company Boasted to Trump About Its Covid-19 Vaccine. Experts Are Skeptical.
-
The Wall Street Journal
During Covid-19 Pandemic, Biotech IPOs Already Surpass Record
-
STAT
Pharma is showering Congress with cash, even amid coronavirus
-
Boston Business Journal
Biogen's Alzheimer's drug has a name. Here's what it is.
Previous
